Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 111 - 120 of 239 results

First page
Previous page
Next page
Next page

TRIDECETH-6

3T5PCR2H0C

Status:

Possibly Marketed Outside US

Source:

21 CFR 333A

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86a6390b-ac33-4a61-bfd2-67704780dfc5

First approved in 2007

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e8821a5-5a09-4373-847d-634c5af1dcec

Class:

POLYMER

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

X3STB5W4PQ

Status:

US Approved Rx (2007)

Source:

BLA125254

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125254

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 NIB-121 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

MJH40NBT7O

Status:

US Approved Rx (2016)

Source:

BLA125285

(2016)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125254

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

23VN4ZWF9A

Status:

US Approved Rx (2007)

Source:

BLA125254

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125254

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

3VSF1BF3SR

Status:

US Approved Rx (2007)

Source:

BLA125254

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125254

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN

4SV59689SK

Status:

US Approved Rx (2007)

Source:

BLA125158

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125158

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

JOJOBA OIL

724GKU717M

Status:

US Previously Marketed

Source:

21 CFR 310.527(a) hair loss prevention jojoba oil

Source URL:

https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-527.xml

First approved in 2007

Source:

21 CFR 333

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d645ab34-1a96-48d1-b9d2-e2dd9e614f78

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) NEURAMINIDASE ANTIGEN (FORMALDEHYDE INACTIVATED)

F3U797X68A

Status:

US Previously Marketed

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

UH52RJ06IG

Status:

US Previously Marketed

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

(2007)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

INFLUENZA VIRUS VACCINE, H5N1 by SANOFI PASTEUR INC

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) hemagglutinin antigen (propiolactone inactivated)

546N59ZB2S

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a06c4ead-c988-4b10-b832-4d7460fa358f

Class:

STRUCTURALLY DIVERSE

Structure of TRIDECETH-6

Polymer

Structurally Diverse

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 NIB-121 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN

Structurally Diverse

JOJOBA OIL

Structurally Diverse

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) NEURAMINIDASE ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) hemagglutinin antigen (propiolactone inactivated)

Showing 111 - 120 of 239 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1